A groundbreaking shift in our drug policy has taken place, as the regulators allow the availability of psilocybin fungi for therapeutic treatment. Previously, these substances were heavily restricted, but a growing body of studies suggests they could offer relief for emotional illnesses like anxiety. This development represents a major step toward